Pharmerit Expands Market Access Support in Asia

/ -- Pharmerit International (Pharmerit), a leading health economics and outcomes research (HEOR) consultancy, is expanding its Asian presence. The expansion includes the growth of the Shanghai, China, office as well as establishment of an office in Mumbai, India.

The Asia-Pacific region is a rapidly growing pharmaceutical and medical device market and an emerging leader in healthcare innovation. Pharmerit's expanded local presence will provide both regional and global sponsors with one-stop market access solutions from a team of in-country experts and affiliates.

"Our expanded presence strengthens our ability to meet the rapidly evolving global evidence and market access requirements," said Marc Botteman, Managing Partner at Pharmerit. "Over the past few years, we have been active in conducting and publishing research relevant to regional decision-makers in countries such as India, China, Taiwan, Japan, Korea, Singapore, Indonesia, Malaysia, and The Philippines. With the addition of Mumbai, we are positioned to work with global sponsors and collaborate with their regional affiliates in Asia's emerging markets by leveraging our regional presence."
About Pharmerit